APA (7th ed.) Citation

Chaudhary, P., Guragain, D., Chang, J., & Kim, J. (2021). TPH1 and 5-HT<sub>7</sub> Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. MDPI AG.

Chicago Style (17th ed.) Citation

Chaudhary, Prakash, Diwakar Guragain, Jae-Hoon Chang, and Jung-Ae Kim. TPH1 and 5-HT<sub>7</sub> Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. MDPI AG, 2021.

MLA (8th ed.) Citation

Chaudhary, Prakash, et al. TPH1 and 5-HT<sub>7</sub> Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. MDPI AG, 2021.

Warning: These citations may not always be 100% accurate.